NCT00812682已完成不适用
Physician and Patient Perception of Adjustable Maintenance Dosing of Symbicort Turbuhaler
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- AstraZeneca
- 入组人数
- 217
- 主要终点
- Patient satisfaction with the adjustable maintenance dosing schedule
研究概览
简要总结
This study will evaluate the perception of the physicians and the patients about the approved adjustable dosing of Symbicort® 160/4,5. Symbicort maintenance dose will be adjusted up and down within the approved dose range of 1x2 - 4x2 inhalations per day, to the level of asthma symptoms. Patients and physicians perception of this new dosing schedule will be evaluated by means of questionnaires completion and direct questioning.
研究设计
- 研究类型
- Observational
- 观察模型
- Case Only
- 时间视角
- Prospective
入排标准
- 年龄范围
- 12 Years 至 —(Child, Adult, Older Adult)
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Minimum of 6 months history of asthma and treatment with an inhaled corticosteroids for at least 3 months prior to visit 1 and/or a history of short term variation in airway function and asthma symptoms responding promptly to convent
- •Patients where use of a combination (inhaled corticosteroid and long acting beta2-agonist is appropriate, i.e. not controlled on inhaled corticosteroids alone).
排除标准
- •Asthma exacerbation requiring oral corticosteroid treatment in the four weeks prior to visit 1
- •Upper Respiratory Tract Infection in the previous four weeks
- •Severe cardiovascular disease or other significant concomitant disease, which may interfere with the conduct of the study.
- •Women enrolled in the trial should not be planning pregnancy and should be taking adequate contraceptive measures where appropriate.
- •Previous enrollment in a clinical study
- •Known or suspected hypersensitivity to budesonide, formoterol or inhaled lactose
结局指标
主要结局
Patient satisfaction with the adjustable maintenance dosing schedule
时间窗: Throughout the study
Physicians' satisfaction with the adjustable maintenance dosing schedule
时间窗: Throughout the study
次要结局
未报告次要终点
研究者
相似试验
已完成
不适用
Quality of Life in IPF - Patient and Physician PerceptionsIdiopathic Pulmonary FibrosisNCT04148157University of Washington100
已完成
不适用
A Study of Clinical Outcomes of the REALIZE Adjustable Gastric Band-CMorbid ObesityNCT00999661Ethicon Endo-Surgery231
已完成
不适用
Patient and Physician Preference Study in Resectable, Non-small Cell Lung Cancer TreatmentsNon-small Cell Lung Cancer (NSCLC)NCT06448793Bristol-Myers Squibb650
已完成
4 期
Study of Patient Use and Perception of the Travatan Dosing AidGlaucomaNCT00626067Wills Eye45
尚未招募
不适用
Real World Difference After Changing Medication From Nonselective to Selective Endothelin Receptor Antagonist in Stable Eisenmenger SyndromeEisenmenger ComplexNCT04732650Samsung Medical Center40
